Literature DB >> 18190460

Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action.

B Sitohy1, S Hammarström, A Danielsson, M-L Hammarström.   

Abstract

Regulatory T cells seem to play a central role in maintaining immune tolerance in the gut mucosa. Previously we have shown that interleukin (IL)-10 is produced at high levels in the inflamed colonic tissue of ulcerative colitis (UC) patients. The cellular source was CD4+ T cells, suggesting local activation of regulatory T cells. The present study was performed to determine whether the frequency of regulatory T cells is increased in UC colon and whether they are present in the basal lymphoid aggregates, the prominent microanatomical structure in UC colon. Colonic tissue specimens from UC and control patients were analysed for frequencies of lamina propria lymphocytes expressing the regulatory T cell markers forkhead box protein 3 (FoxP3), CD25 and glucocorticoid-induced tumour necrosis factor receptor family-related gene (GITR) as well as CD28, CD4 and CD3 by using marker specific reagents in immunomorphometry. Two-colour immunohistochemistry was used for detection of CD25/IL-10, FoxP3/IL-10 and CD25/FoxP3 double-positive cells. GITR+ and FoxP3+ cells were present in normal colon mucosa, although at a relatively low frequency, and were located preferentially within the solitary follicles. UC was associated with significantly increased frequencies of CD25+, GITR+ and FoxP3+ lamina propria lymphocytes both within the basal lymphoid aggregates and in the lamina propria outside. Many of the CD25+ cells co-expressed FoxP3 as well as IL-10, suggesting that these are indeed IL-10 secreting regulatory T cells, activated in an attempt to counteract the inflammation. Increased frequency of regulatory T cell subtypes seems insufficient to control the disease activity in UC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190460      PMCID: PMC2276944          DOI: 10.1111/j.1365-2249.2007.03566.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Foxp3: a critical regulator of the development and function of regulatory T cells.

Authors:  Shohei Hori; Shimon Sakaguchi
Journal:  Microbes Infect       Date:  2004-07       Impact factor: 2.700

Review 2.  IL-2, regulatory T cells, and tolerance.

Authors:  Brad H Nelson
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

3.  Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo.

Authors:  Bruno Martin; Alice Banz; Boris Bienvenu; Corinne Cordier; Nicole Dautigny; Chantal Bécourt; Bruno Lucas
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 4.  Regulatory T cells: peace keepers in the gut.

Authors:  Matthieu Allez; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2004-09       Impact factor: 5.325

5.  Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells.

Authors:  Christian Mottet; Holm H Uhlig; Fiona Powrie
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

6.  CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.

Authors:  Shin Makita; Takanori Kanai; Shigeru Oshima; Koji Uraushihara; Teruji Totsuka; Taisuke Sawada; Tetsuya Nakamura; Kazutaka Koganei; Tsuneo Fukushima; Mamoru Watanabe
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

7.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

Authors:  Ivan J Fuss; Frank Heller; Monica Boirivant; Francisco Leon; Masaru Yoshida; Stefan Fichtner-Feigl; Zhiqiong Yang; Mark Exley; Atsushi Kitani; Richard S Blumberg; Peter Mannon; Warren Strober
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium.

Authors:  Anna K Ildgruben; Inga M Sjöberg; Marie-Louise K C Hammarström
Journal:  Obstet Gynecol       Date:  2003-09       Impact factor: 7.661

9.  GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations.

Authors:  Simona Ronchetti; Ornella Zollo; Stefano Bruscoli; Massimiliano Agostini; Rodolfo Bianchini; Giuseppe Nocentini; Emira Ayroldi; Carlo Riccardi
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

10.  CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.

Authors:  Ann E Herman; Gordon J Freeman; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2004-06-07       Impact factor: 14.307

View more
  16 in total

1.  Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease.

Authors:  Kyoichi Kato; Ken Fukunaga; Koji Kamikozuru; Shinichiro Kashiwamura; Nobuyuki Hida; Yoshio Ohda; Naohisa Takeda; Koji Yoshida; Masaki Iimuro; Yoko Yokoyama; Risa Kikuyama; Hiroto Miwa; Takayuki Matsumoto
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

Review 2.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

3.  Enhanced oxidative phosphorylation of IgG plasma cells can contribute to hypoxia in the mucosa of active ulcerative colitis.

Authors:  Yoshihiro Nagase; Makoto Kodama; Keiko Abe; Masayuki Fukata; Tetsuo Yamana; Nobuyuki Igarashi
Journal:  Histochem Cell Biol       Date:  2022-06-18       Impact factor: 2.531

4.  The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease.

Authors:  K Kamikozuru; K Fukunaga; S Hirota; N Hida; Y Ohda; K Yoshida; Y Yokoyama; K Tozawa; K Kawa; M Iimuro; K Nagase; A R Saniabadi; S Nakamura; H Miwa; T Matsumoto
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

5.  Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

Authors:  Nicola Eastaff-Leung; Nicholas Mabarrack; Angela Barbour; Adrian Cummins; Simon Barry
Journal:  J Clin Immunol       Date:  2010-01       Impact factor: 8.317

Review 6.  IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction.

Authors:  Bana Jabri; Valérie Abadie
Journal:  Nat Rev Immunol       Date:  2015-11-16       Impact factor: 53.106

7.  T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.

Authors:  Suresh Gopi Kalathil; Amit Anand Lugade; Vandana Pradhan; Austin Miller; Ganapathi Iyer Parameswaran; Sanjay Sethi; Yasmin Thanavala
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 8.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

Review 9.  Human gut-associated lymphoid tissues (GALT); diversity, structure, and function.

Authors:  Urs M Mörbe; Peter B Jørgensen; Thomas M Fenton; Nicole von Burg; Lene B Riis; Jo Spencer; William W Agace
Journal:  Mucosal Immunol       Date:  2021-03-22       Impact factor: 7.313

10.  Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation.

Authors:  Franziska Boehm; Maria Martin; Rebecca Kesselring; Gabriela Schiechl; Edward K Geissler; Hans-Jürgen Schlitt; Stefan Fichtner-Feigl
Journal:  BMC Gastroenterol       Date:  2012-07-31       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.